Latest revenue
$320.6M
as of 2026-03-31
Latest net income
$1.8M
as of 2026-03-31
Net margin
0.6%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $287.9M
- Enterprise value
- $287.9M
- P/E (trailing)
- 1.8×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 4.0%
- 52-wk high
- $14.62
- 52-wk low
- $5.62
- Beta
- —
- Shares out
- 48.6M
5-year trend
What this company does
ITEM 1. BUSINESS Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, our revenue of $1.5 billion was primarily generated by our two primary product categories: beauty products and wellness products. We operate in the direct selling channel, primarily utilizing person-to-person marketing to promote and sell our products, including through the use of social and digital platforms. In addition to our core Nu Skin business, we also explore new areas of synergistic and adjacent growth through our strategic investment arm known as Rhyz Inc., which we formed in 2018. Our Rhyz businesses…
AI summary unavailable — showing raw filing excerpt
Generated from NUS's filing dated 2026-02-13
Key risks
ITEM 1A. RISK FACTORS Risk Factor Summary We are providing the following summary of the risk factors contained in this Annual Report on Form 10-K to enhance the readability and accessibility of our risk factor disclosures. We encourage you to carefully review the full risk factors contained after this summary for additional information regarding the material factors that make an investment in our securities speculative or risky. These risks include the following: Risks Associated with Direct Selling and Our Sales Force ● Challenges to the form of our network marketing system or to our business practices have harmed and could continue to harm our business. ● Direct selling laws and…
AI summary unavailable — showing raw filing excerpt
Generated from NUS's filing dated 2026-02-13
Profitability
Gross margin
69.4%
1.8%Operating margin
4.4%
150.6%Net margin
10.8%
227.5%Return on equity
19.9%
188.4%Return on assets
11.4%
214.2%Leverage
Debt / equity
0.75×
40.6%Long-term debt / equity
0.25×
54.6%Debt / assets
42.7%
23.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $320.6M | -12.0% | $1.8M | -98.3% | 0.6% |
Q4 2025 2025-12-31 | $370.3M | -16.9% | $14.5M | +140.1% | 3.9% |
Q3 2025 2025-09-30 | $364.2M | -15.3% | $17.1M | +105.7% | 4.7% |
Q2 2025 2025-06-30 | $386.1M | -12.1% | $21.1M | +117.9% | 5.5% |
Q1 2025 2025-03-31 | $364.5M | -12.7% | $107.5M | +20271.7% | 29.5% |
Q4 2024 2024-12-31 | $445.6M | — | $-36.1M | — | -8.1% |
Q3 2024 2024-09-30 | $430.1M | -13.8% | $8.3M | +532.3% | 1.9% |
Q2 2024 2024-06-30 | $439.1M | -12.2% | $-118.3M | -539.8% | -26.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Wholesale-Drugs, Proprietaries & Druggists' Sundries · SIC 5122
Your notes
Keep private notes on NUS — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$101.9K
Insider selling
$805.9K
Net activity
−$704.0K
Distinct insiders
6
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns NUS
Institutional value
$124.8M
Total shares held
19.0M
Distinct holders
99
-85 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.3M | $31.2M | -24.2K (-0.6%) | Trimmed |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $15.0M | — | New |
| 3 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 1.8M | $13.1M | +60.0K (+3.5%) | Added |
| 4 | DIMENSIONAL FUND ADVISORS LP | 1.7M | $12.6M | +361.8K (+26.3%) | Added |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | $12.4M | — | New |
| 6 | Bank of New York Mellon Corp | 540.8K | $3.9M | -122 (-0.0%) | Trimmed |
| 7 | PRUDENTIAL FINANCIAL INC | 376.8K | $2.7M | +213.0K (+130.1%) | Added |
| 8 | Connor, Clark & Lunn Investment Management Ltd. | 366.0K | $2.7M | -44.9K (-10.9%) | Trimmed |
| 9 | Allianz Asset Management GmbH | 330.5K | $2.4M | +99.9K (+43.3%) | Added |
| 10 | VANGUARD FIDUCIARY TRUST CO | 309.2K | $2.3M | — | New |
| 11 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 275.0K | $2.0M | +24.8K (+9.9%) | Added |
| 12 | UBS Group AG | 236.0K | $1.7M | -113.4K (-32.5%) | Trimmed |
| 13 | Vanguard Global Advisers, LLC | 229.2K | $1.7M | — | New |
| 14 | JPMORGAN CHASE & CO | 207.3K | $1.5M | -240.3K (-53.7%) | Trimmed |
| 15 | RITHOLTZ WEALTH MANAGEMENT | 179.2K | $1.3M | +27.3K (+18.0%) | Added |
| 16 | Creative Planning | 169.2K | $1.2M | +67.1K (+65.7%) | Added |
| 17 | WEDGE CAPITAL MANAGEMENT L L P/NC | 166.6K | $1.2M | +60.4K (+56.9%) | Added |
| 18 | Nuveen, LLC | 158.7K | $1.2M | +1.5K (+1.0%) | Added |
| 19 | Y-Intercept (Hong Kong) Ltd | 154.9K | $1.1M | +3.7K (+2.5%) | Added |
| 20 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 144.6K | $1.1M | -11.3K (-7.3%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once NUS's latest filing finishes processing.